SAREPTA THERAPEUTICS INC (1SRPT.MI) Stock Earnings & Estimates
Europe - BIT:1SRPT - US8036071004 - Common Stock
16.07 EUR
-4.36 (-21.34%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 933M 32.92% | 1.243B 33.26% | 1.902B 52.97% | 2.086B 9.68% | 1.627B -22.00% | 1.507B -7.38% | 1.436B -4.71% | 1.463B 1.88% | 1.406B -3.90% | 1.416B 0.71% | 1.439B 1.62% | |
| EBITDA YoY % growth | -494.3M -20.06% | -223.427M 54.80% | 255.805M 214.49% | -320.688M -225.36% | 457.27M 242.59% | 358.22M -21.66% | 458.31M 27.94% | 407.41M -11.11% | N/A | N/A | N/A | |
| EBIT YoY % growth | -536.2M -19.24% | -267.824M 50.05% | 218.081M 181.43% | -440.158M -301.83% | 330.91M 175.18% | 218.82M -33.87% | 118.82M -45.70% | 264.45M 122.56% | 131.28M -50.36% | 86.392M -34.19% | 65.017M -24.74% | |
| Operating Margin | -57.47% | -21.54% | 11.47% | -21.10% | 20.34% | 14.52% | 8.27% | 18.08% | 9.34% | 6.10% | 4.52% | |
| EPS YoY % growth | -8.03 -33.61% | -6.12 23.79% | 2.28 137.25% | -4.45 -295.33% | 2.39 153.57% | 2.43 1.92% | 3.37 38.48% | 3.24 -3.70% | 2.90 -10.71% | 3.35 15.65% | 3.41 1.90% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 -349.66% | -1.21 -180.80% | 0.53 111.53% | 0.78 -58.81% | 0.76 189.85% | 0.62 151.05% |
| Revenue Q2Q % growth | 342.83M -26.62% | 359.81M -45.35% | 413.05M -44.55% | 423.5M -30.70% | 426.75M 24.48% | 449.23M 24.85% |
| EBITDA Q2Q % growth | -110.546M -323.48% | -114.925M -157.63% | 11.835M 104.08% | 11.897M -91.28% | N/A | N/A |
| EBIT Q2Q % growth | -103.176M -564.84% | -179.074M -210.76% | 37.53M 112.49% | 67.715M -41.41% | 43.744M 142.40% | 53.183M 129.70% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.89 2,600.00% | 0.77 | 1.12 | 146.84% |
| Q1 2025 Q2Q % growth | -4.60 -1,343.24% | -0.97 | -3.63 | -376.26% |
| Q4 2024 Q2Q % growth | 1.50 219.15% | 1.93 | -0.43 | -22.48% |
| Q3 2024 Q2Q % growth | 0.34 173.91% | -0.14 | 0.48 | 348.76% |
| Q2 2024 Q2Q % growth | 0.07 125.93% | 0.01 | 0.06 | 1,173.24% |
| Q1 2024 Q2Q % growth | 0.37 106.31% | -0.08 | 0.45 | 585.99% |
| Q4 2023 Q2Q % growth | 0.47 137.90% | 0.02 | 0.45 | 3,019.73% |
| Q3 2023 Q2Q % growth | -0.46 84.35% | -1.26 | 0.80 | 63.36% |
| Q2 2023 Q2Q % growth | -0.27 89.81% | -1.81 | 1.54 | 85.10% |
| Q1 2023 Q2Q % growth | -5.86 -388.33% | -1.41 | -4.45 | -315.34% |
| Q4 2022 Q2Q % growth | -1.24 12.68% | -1.37 | 0.13 | 9.79% |
| Q3 2022 Q2Q % growth | -2.94 -1,447.37% | -1.46 | -1.48 | -101.24% |
| Q2 2022 Q2Q % growth | -2.65 -15.22% | -1.20 | -1.45 | -120.48% |
| Q1 2022 Q2Q % growth | -1.20 42.86% | -1.30 | 0.10 | 7.43% |
| Q4 2021 Q2Q % growth | -1.42 40.83% | -1.15 | -0.27 | -23.12% |
| Q3 2021 Q2Q % growth | -0.19 90.16% | -1.93 | 1.74 | 90.17% |
| Q2 2021 Q2Q % growth | -2.30 -19.17% | -1.30 | -1.00 | -76.76% |
| Q1 2021 Q2Q % growth | -2.10 -813.04% | -1.78 | -0.32 | -18.05% |
| Q4 2020 Q2Q % growth | -2.40 24.05% | -1.92 | -0.48 | -25.20% |
| Q3 2020 Q2Q % growth | -1.93 -13.53% | -1.75 | -0.18 | -10.52% |
| Q2 2020 Q2Q % growth | -1.93 -38.85% | -1.79 | -0.14 | -7.69% |
| Q1 2020 Q2Q % growth | -0.23 78.50% | -1.91 | 1.68 | 87.98% |
| Q4 2019 Q2Q % growth | -3.16 | -1.90 | -1.26 | -66.36% |
| Q3 2019 Q2Q % growth | -1.70 | -1.38 | -0.32 | -23.51% |
| Q2 2019 Q2Q % growth | -1.39 | -1.40 | 0.01 | 0.80% |
| Q1 2019 Q2Q % growth | -1.07 | -1.73 | 0.66 | 38.31% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 611.091M 68.38% | 540.58M | 70.511M | 13.04% |
| Q1 2025 Q2Q % growth | 744.856M 80.15% | 697.02M | 47.836M | 6.86% |
| Q4 2024 Q2Q % growth | 658.412M 65.94% | 640.13M | 18.282M | 2.86% |
| Q3 2024 Q2Q % growth | 467.172M 40.80% | 417.48M | 49.692M | 11.90% |
| Q2 2024 Q2Q % growth | 362.931M 38.95% | 399.23M | -36.299M | -9.09% |
| Q1 2024 Q2Q % growth | 413.464M 63.10% | 385.34M | 28.124M | 7.30% |
| Q4 2023 Q2Q % growth | 396.781M 53.55% | 394.03M | 2.751M | 0.70% |
| Q3 2023 Q2Q % growth | 331.8M 44.07% | 291.04M | 40.76M | 14.00% |
| Q2 2023 Q2Q % growth | 261.2M 11.86% | 264.74M | -3.54M | -1.34% |
| Q1 2023 Q2Q % growth | 253.5M 20.26% | 246.79M | 6.71M | 2.72% |
| Q4 2022 Q2Q % growth | 258.4M 28.24% | 253.3M | 5.1M | 2.01% |
| Q3 2022 Q2Q % growth | 230.3M 21.59% | 239.21M | -8.91M | -3.72% |
| Q2 2022 Q2Q % growth | 233.5M 42.29% | 225.23M | 8.27M | 3.67% |
| Q1 2022 Q2Q % growth | 210.8M 43.50% | 210.57M | 230K | 0.11% |
| Q4 2021 Q2Q % growth | 201.5M 38.87% | 202.58M | -1.08M | -0.53% |
| Q3 2021 Q2Q % growth | 189.4M 31.62% | 176.89M | 12.51M | 7.07% |
| Q2 2021 Q2Q % growth | 164.1M 19.43% | 165.91M | -1.81M | -1.09% |
| Q1 2021 Q2Q % growth | 146.9M 29.20% | 146.2M | 700K | 0.48% |
| Q4 2020 Q2Q % growth | 145.1M 44.96% | 149.22M | -4.12M | -2.76% |
| Q3 2020 Q2Q % growth | 143.9M 45.35% | 140.18M | 3.72M | 2.65% |
| Q2 2020 Q2Q % growth | 137.4M 45.09% | 119.47M | 17.93M | 15.01% |
| Q1 2020 Q2Q % growth | 113.7M 30.69% | 121.42M | -7.72M | -6.36% |
| Q4 2019 Q2Q % growth | 100.1M | 100.83M | -730K | -0.72% |
| Q3 2019 Q2Q % growth | 99M | 100.3M | -1.3M | -1.30% |
| Q2 2019 Q2Q % growth | 94.7M | 92.757M | 1.943M | 2.09% |
| Q1 2019 Q2Q % growth | 87M | 88.285M | -1.285M | -1.46% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.92% | -1852.02% | 0.72% | -6.79% |
| Revenue | 1.93% | -32.18% | 0.24% | -8.55% |